Fox Run Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-35,052
Closed -$324K 1226
2026
Q1
$324K Buy
35,052
+25,007
+249% +$229K 0.06% 599
2025
Q4
$95.9K Sell
10,045
-34,287
-77% -$349K 0.01% 856
2025
Q3
$433K Buy
+44,332
New +$341K 0.07% 554
2024
Q3
Sell
-18,591
Closed -$384K 1045
2024
Q2
$384K Buy
+18,591
New +$402K 0.07% 495
2024
Q1
Sell
-6,403
Closed -$233K 1000
2023
Q4
$233K Sell
6,403
-3,214
-33% -$124K 0.06% 589
2023
Q3
$464K Buy
+9,617
New +$571K 0.14% 291
2022
Q4
Sell
-7,126
Closed -$432K 835
2022
Q3
$432K Sell
7,126
-5,792
-45% -$183K 0.17% 231
2022
Q2
$351K Buy
+12,918
New +$378K 0.18% 233
2018
Q3
Sell
-26,113
Closed -$381K 774
2018
Q2
$381K Buy
+26,113
New +$516K 0.12% 344

Other funds holding PRTA

Fox Run Management's PRTA Position: Q2 2026 in Review

Fox Run Management sold out of Prothena Corp (PRTA) in Q2 2026, closing a stake of 35,052 shares — an estimated $324K sold.

Fox Run Management first reported a position in PRTA in Q2 2018 and held it in 9 quarters. The position peaked at $464K in Q3 2023. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Fox Run Management reported no remaining Prothena Corp position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 35,052 Prothena Corp shares in Q2 2026, an estimated $324K.
  • Fox Run Management first reported a position in Prothena Corp in Q2 2018 and held it in 9 quarters.
  • Fox Run Management's Prothena Corp position peaked at $464K in Q3 2023.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.